Insider Transactions in Q1 2023 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2023
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
1,948
-1.44%
|
$87,660
$45.04 P/Share
|
|
Mar 06
2023
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,059
-2.62%
|
$137,655
$45.0 P/Share
|
|
Mar 06
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
1,875
-3.41%
|
$84,375
$45.0 P/Share
|
|
Mar 06
2023
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,158
-2.96%
|
$142,110
$45.0 P/Share
|
|
Mar 06
2023
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,676
-2.55%
|
$75,420
$45.06 P/Share
|
|
Mar 06
2023
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,514
-1.9%
|
$68,130
$45.25 P/Share
|
|
Mar 06
2023
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,640
-2.51%
|
$298,800
$45.19 P/Share
|
|
Mar 06
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,126
-3.69%
|
$50,670
$45.06 P/Share
|
|
Mar 06
2023
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,007
-2.92%
|
$135,315
$45.1 P/Share
|
|
Mar 06
2023
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,322
-2.97%
|
$149,490
$45.07 P/Share
|
|
Mar 06
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
9,793
-2.68%
|
$430,892
$45.0 P/Share
|
|
Mar 06
2023
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
761
-0.92%
|
$34,245
$45.25 P/Share
|
|
Mar 01
2023
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+23.28%
|
-
|
|
Mar 01
2023
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+27.56%
|
-
|
|
Mar 01
2023
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+18.99%
|
-
|
|
Mar 01
2023
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+19.52%
|
-
|
|
Mar 01
2023
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+23.9%
|
-
|
|
Mar 01
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+26.17%
|
-
|
|
Mar 01
2023
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+20.43%
|
-
|
|
Mar 01
2023
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+23.22%
|
-
|
|
Mar 01
2023
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+18.12%
|
-
|
|
Mar 01
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+24.09%
|
-
|
|
Mar 01
2023
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+18.25%
|
-
|
|
Jan 06
2023
|
John Tsai |
BUY
Grant, award, or other acquisition
|
Direct |
3,900
+50.0%
|
-
|